Cancer Therapy: A Role For MAPK Inhibitors Combined With MTORC1 Inhibitors Nearly a decade ago, while it was being tested as an immunosuppressive agent to prevent organ rejection in transplant patients, the drug rapamycin was also discovered to have anti-tumor properties. Since then, several rapamycin analogs known as mTOR (mammalian target of rapamycin) inhibitors have been tested in clinical trials for the treatment of various types of cancer.
Source: www.medicalnewstoday.comTobacco Industry's Marketing Linked To Youth Smoking The National Cancer Institute (NCI) has released a report, co-edited by University of Minnesota professor Barbara Loken, that reaches the government's strongest conclusion to date that tobacco marketing and depictions of smoking in movies promote youth smoking.
Source: www.medicalnewstoday.comRapid Test For Pathogens Developed By K-State Researchers Could Be Used To Detect Diseases Used By Bioterrorists Dangerous disease often spreads faster than it takes to diagnose it in the lab. To remedy that, researchers at Kansas State University have developed a test to bring that time from days down to hours.
Source: www.medicalnewstoday.comShingles Pain Treatment Will Benefit More Patients The medicated pain relief plaster, (Versatis) is now approved by the Scottish
Medicines Consortium (SMC) for restricted use within NHS Scotland for patients suffering pain following shingles(1) http://www.scottish
medicines.org.uk/smc/5850.html.
Source: www.medicalnewstoday.comNew Drug Delivery System Breaks The 'Mucus Barrier' Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases.
Source: www.medicalnewstoday.comPsoriasis: More Than Skin Deep Psoriasis is a chronic disease of the immune system that affects the skin. As many as 7.5 million Americans suffer from psoriasis, according to the National Institutes of
Health. Unlike other diseases of the immune system which affect women more often than men, psoriasis occurs about equally in men and women. Psoriasis is not contagious and cannot be spread from person to person.
Source: www.medicalnewstoday.comPain Therapeutics And King Pharmaceuticals Announce Final Data Of REMOXY Phase III Study At World Pain Congress Pain Therapeutics, Inc. (NASDAQ: PTIE) and King Pharmaceuticals, Inc. (NYSE: KG) today presented the final data set of a previously announced pivotal Phase III study of REMOXY®, an investigational drug to treat chronic pain. The final data confirm REMOXY provides effective around-the-clock analgesia within a patented formulation designed to resist common methods of misuse and abuse.
Source: www.medicalnewstoday.comLink Between E. coli And Distillers' Grains Studied By Researchers A research team headed by Kansas State University E. coli O157:H7 expert T.G. Nagaraja has been tapped by the U.S. Department of Agriculture to study both the connection between feeding distillers' grains and E. coli 0157:H7 in cattle and several strategies to reduce the presence of the naturally occurring pathogen in the animals.
Source: www.medicalnewstoday.comFDA Approves Vidaza Label Expansion The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to inform patients that the U.S. Food & Drug Administration (FDA) has expanded the label for VIDAZA (azacitidine) to include data from the AZA-001 trial, which found that Vidaza is the only agent that extends survival in MDS (myelodysplastic syndromes) patients.
Source: www.medicalnewstoday.com
# posted by Network @ 8:00 AM
